<DOC>
	<DOCNO>NCT00309049</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics oral Ixabepilone .</brief_summary>
	<brief_title>Ixabepilone Administered Enteric Coated Formulation .</brief_title>
	<detailed_description />
	<mesh_term>Epothilones</mesh_term>
	<criteria>ECOG status 02 . Unable swallow pill . Current recent GI disease GI surgery . Brain mets . Severe nerve damage . ANC &lt; 1,500/mm3 Platelets &lt; 125K . Bilirubin &gt; =1.5 time IULN . ALT/AST &gt; =1.5 time IULN . Creatine &gt; 1.5 time IULN . Prior treatment Ixabepilone . Strong use CYPP450 drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>